Imodium Comp

Dimeticone and Loperamide Hydrochloride, the active ingredients in Imodium Comp, are an opioid receptor agonist (antidiarrheal) and an antiflatulent presented as an oral formulation for OTC use. It treats acute diarrhea, travelers' diarrhea, and flatulence in adults and children as appropriate.

GNH USA supplies Imodium Comp as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imodium Comp acts on the gastrointestinal tract to control excess stool frequency and reduce gas buildup.

Acute diarrhea: restores normal stool consistency and reduces frequency. Travelers' diarrhea: provides rapid symptom relief for short‑term travel‑related loose stools. Flatulence: diminishes gas bubbles, easing abdominal discomfort.

Common Side Effects: - Constipation: reduced bowel movements may become infrequent. - Abdominal cramps: mild discomfort in the abdomen. - Nausea: occasional feeling of queasiness. - Dizziness: transient light‑headedness. - Dry mouth: reduced salivation. - Flatulence reduction: may cause a feeling of gas release.

Serious or Rare Side Effects: - Severe constipation or intestinal obstruction: risk of blockage. - Toxic megacolon: rare but life‑threatening colonic dilation. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Cardiac arrhythmia: especially with high systemic loperamide levels. - Persistent abdominal pain: may indicate serious underlying condition. - Hepatotoxicity: rare liver enzyme elevations.

Before using Imodium Comp, consider the following precautions.

Do not exceed recommended dose: follow label or prescriber guidance. Avoid use in bacterial enterocolitis: may worsen infection. Use with caution in hepatic impairment: reduced drug clearance. Avoid concomitant strong CYP3A4 inhibitors: may increase systemic exposure. Pregnancy and breastfeeding: consult a healthcare professional before use. Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Imodium Comp may interact with other medicines; review the following.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): increase loperamide plasma levels. - Other opioid agonists: additive central nervous system depression. - QT‑prolonging agents (e.g., quinidine): heightened risk of cardiac arrhythmia.

Moderate Interactions (Monitor Closely): - Anticholinergic drugs: may exacerbate constipation. - Other antidiarrheal agents (e.g., bismuth subsalicylate): may reduce overall efficacy. - Antiflatulent products: generally safe but monitor for overlapping effects.